How are Buffalo Translational Consortium researchers navigating the use of artificial intelligence (AI) in research? How is AI advancing translational science?

A powerful new software platform called the Playbook Workflow Builder is set to transform biomedical research by allowing ...

Nursing is a rewarding yet demanding profession requiring resilience in physical, emotional, and mental capacities. Despite their critical role in healthcare, breakrooms—designed to support nurses’ ...

A new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University, shows how common gut bacteria can metabolize certain oral medications that target ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

The technology, which in the past had been limited by size and cost, provides targeted doses of radiation to tumors, ...

A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and protects replicating DNA in dividing cells. This new structural and ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...

A tower crane has been installed for construction of the Wichita Biomedical Campus in downtown, marking the next significant ...

Scientists created a stem cell-based method to produce high-quality mitochondria at scale, enabling effective treatments for ...

Ethan Grimes, BS, and Paul Morgan, MD, conduct rational drug design at the newly launched AI Small Molecule Drug Discovery Center at the Icahn School of Medicine at Mount Sinai. As part of Mount Sinai ...